EW Edwards Lifesciences
NYSE · SEC CIK 1099800 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $27.68M 42 sales by 9 insiders
- Filings on record
- 445 since 2021-07-01, latest 2026-09-14 18:04
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| BOBO DONALD E JR | CVP, Strategy, Corp Development | — | $11.15M |
| Zovighian Bernard J | CEO, Dir | — | $7.00M |
| Ullem Scott B. | CFO, CVP | — | $3.87M |
| Chopra Daveen | CVP, TMTT, Surgical, IHFM | — | $3.19M |
| Markowitz Wayne | CVP, JAPAC | — | $1.04M |
| Lippis Daniel J. | CVP, TAVR | — | $871.6K |
| Bruls Annette | CVP, EMEACLA | — | $237.9K |
| STONE HEISZ LESLIE | Dir | — | $218.1K |
| Dahl Andrew M. | SVP, Corp. Ctrl | — | $98.4K |
| Davis Leslie C. | Dir | — | — |
Transactions 820
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-10 | 2023-10-10 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $36.75 | +5,000 | 39.8K | +14% | +$183.8K |
| D | 2023-10-10 | 2023-10-10 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $72.68 | -5,000 | 34.8K | -13% | -$363.4K |
| D | 2023-10-03 | 2023-10-03 | EW | Chopra Daveen | CVP, TMTT | S - Sale+OE | $70.00 | -8,500 | 23.9K | -26% | -$595.0K |
| D | 2023-10-03 | 2023-10-03 | EW | Chopra Daveen | CVP, TMTT | M - OptEx | $59.26 | +8,500 | 32.5K | +35% | +$503.7K |
| D | 2023-10-02 | 2023-10-02 | EW | MUSSALLEM MICHAEL A | Dir | M - OptEx | $36.75 | +29.4K | 33.8K | +654% | +$1.08M |
| D | 2023-10-02 | 2023-10-02 | EW | MUSSALLEM MICHAEL A | Dir | S - Sale+OE | $68.84 | -29.4K | 4,486 | -87% | -$2.02M |
| D | 2023-09-29 | 2023-09-29 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $69.54 | -7,255 | 19.2K | -27% | -$504.5K |
| D | 2023-09-29 | 2023-09-29 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,255 | 26.5K | +38% | +$266.6K |
| D | 2023-09-15 | 2023-09-14 | EW | Markowitz Wayne | SVP, GM, Surgical | A - Grant | $0.00 | +7,262 | 7,262 | New | $0 |
| D | 2023-09-14 | 2023-09-14 | EW | Wood Larry L | Gbl Pres TAVR, Surg | S - Sale+OE | $73.63 | -8,660 | 213.8K | -4% | -$637.6K |
| D | 2023-09-14 | 2023-09-14 | EW | Wood Larry L | Gbl Pres TAVR, Surg | M - OptEx | $45.28 | +8,660 | 222.5K | +4% | +$392.1K |
| D | 2023-09-14 | 2023-09-14 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $73.71 | -4,500 | 39.5K | -10% | -$331.7K |
| D | 2023-09-14 | 2023-09-14 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $36.75 | +4,500 | 44.0K | +11% | +$165.4K |
| D | 2023-09-08 | 2023-09-08 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $76.00 | -5,000 | 34.8K | -13% | -$380.0K |
| D | 2023-09-08 | 2023-09-08 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $36.75 | +5,000 | 39.8K | +14% | +$183.8K |
| D | 2023-09-06 | 2023-09-06 | EW | Chopra Daveen | CVP, TMTT | M - OptEx | $59.26 | +8,500 | 32.5K | +35% | +$503.7K |
| D | 2023-09-06 | 2023-09-06 | EW | Chopra Daveen | CVP, TMTT | S - Sale+OE | $76.07 | -8,500 | 23.9K | -26% | -$646.6K |
| D | 2023-09-05 | 2023-09-05 | EW | MUSSALLEM MICHAEL A | Dir | M - OptEx | $36.75 | +29.4K | 33.8K | +654% | +$1.08M |
| D | 2023-09-05 | 2023-09-05 | EW | MUSSALLEM MICHAEL A | Dir | S - Sale+OE | $75.86 | -29.4K | 4,486 | -87% | -$2.23M |
| D | 2023-08-31 | 2023-08-31 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,255 | 26.5K | +38% | +$266.6K |
| D | 2023-08-31 | 2023-08-31 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $77.79 | -7,255 | 19.2K | -27% | -$564.4K |
| 2023-08-31 | 2023-08-31 | EW | MUSSALLEM MICHAEL A | Dir | G - Gift | $0.00 | -49.8K | 4,486 | -92% | $0 | |
| I | 2023-08-31 | 2023-08-31 | EW | MUSSALLEM MICHAEL A | Dir | G - Gift | $0.00 | +49.8K | 3.67M | +1% | $0 |
| 2023-08-29 | 2023-08-29 | EW | Chopra Daveen | CVP, TMTT | S - Sale | $76.69 | -1,500 | 23.9K | -6% | -$115.0K | |
| D | 2023-08-14 | 2023-08-14 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $36.75 | +4,500 | 44.0K | +11% | +$165.4K |
| D | 2023-08-14 | 2023-08-14 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $79.30 | -4,500 | 39.5K | -10% | -$356.9K |
| D | 2023-08-14 | 2023-08-14 | EW | Wood Larry L | Gbl Pres TAVR, Surg | S - Sale+OE | $79.30 | -6,421 | 213.8K | -3% | -$509.2K |
| D | 2023-08-14 | 2023-08-14 | EW | Wood Larry L | Gbl Pres TAVR, Surg | M - OptEx | $45.28 | +6,421 | 220.2K | +3% | +$290.7K |
| 2023-08-10 | 2023-08-10 | EW | STONE HEISZ LESLIE | Dir | S - Sale | $78.87 | -3,303 | 27.0K | -11% | -$260.5K | |
| D | 2023-08-09 | 2023-08-09 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $78.64 | -5,000 | 34.8K | -13% | -$393.2K |
| D | 2023-08-09 | 2023-08-09 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $36.75 | +5,000 | 39.8K | +14% | +$183.8K |
| D | 2023-08-07 | 2023-08-07 | EW | MUSSALLEM MICHAEL A | Dir | M - OptEx | $36.75 | +29.4K | 83.6K | +54% | +$1.08M |
| DM | 2023-08-07 | 2023-08-07 | EW | MUSSALLEM MICHAEL A | Dir | S - Sale+OE | $79.87 | -29.4K | 54.3K | -35% | -$2.34M |
| 2023-08-01 | 2023-07-31 | EW | Zovighian Bernard J | CEO, Dir | I - Discretionary | $83.54 | +2,559 | 47.1K | +6% | +$213.7K | |
| D | 2023-07-31 | 2023-07-31 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,255 | 26.5K | +38% | +$266.6K |
| D | 2023-07-31 | 2023-07-31 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $84.35 | -7,255 | 19.2K | -27% | -$612.0K |
| D | 2023-07-14 | 2023-07-14 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $36.75 | +3,500 | 43.0K | +9% | +$128.6K |
| D | 2023-07-14 | 2023-07-14 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $92.94 | -3,500 | 39.5K | -8% | -$325.3K |
| D | 2023-07-14 | 2023-07-14 | EW | Wood Larry L | Gbl Pres TAVR, Surg | M - OptEx | $45.28 | +8,660 | 222.5K | +4% | +$392.1K |
| D | 2023-07-14 | 2023-07-14 | EW | Wood Larry L | Gbl Pres TAVR, Surg | S - Sale+OE | $92.94 | -8,660 | 213.8K | -4% | -$804.9K |
| D | 2023-07-10 | 2023-07-07 | EW | Szyman Catherine M. | CVP, Critical Care | F - Tax | $90.46 | -252 | 34.8K | -0.7% | -$22.8K |
| D | 2023-07-10 | 2023-07-10 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $36.75 | +5,000 | 39.8K | +14% | +$183.8K |
| D | 2023-07-10 | 2023-07-10 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $90.52 | -5,000 | 34.8K | -13% | -$452.6K |
| 2023-07-07 | 2023-07-07 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | F - Tax | $90.46 | -81 | 173.6K | -0.0% | -$7,327 | |
| DM | 2023-07-05 | 2023-07-05 | EW | MUSSALLEM MICHAEL A | Dir | S - Sale+OE | $90.78 | -29.4K | 76.0K | -28% | -$2.66M |
| D | 2023-07-05 | 2023-07-05 | EW | MUSSALLEM MICHAEL A | Dir | M - OptEx | $36.75 | +29.4K | 83.6K | +54% | +$1.08M |
| D | 2023-06-30 | 2023-06-30 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,255 | 26.5K | +38% | +$266.6K |
| D | 2023-06-30 | 2023-06-30 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $93.27 | -7,255 | 19.2K | -27% | -$676.7K |
| D | 2023-06-14 | 2023-06-14 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $89.77 | -3,500 | 39.5K | -8% | -$314.2K |
| D | 2023-06-14 | 2023-06-14 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $36.75 | +3,500 | 43.0K | +9% | +$128.6K |
| DM | 2023-06-14 | 2023-06-14 | EW | Wood Larry L | Gbl Pres TAVR, Surg | S - Sale+OE | $90.15 | -8,660 | 213.8K | -4% | -$780.7K |
| D | 2023-06-14 | 2023-06-14 | EW | Wood Larry L | Gbl Pres TAVR, Surg | M - OptEx | $45.28 | +8,660 | 222.5K | +4% | +$392.1K |
| D | 2023-06-13 | 2023-06-13 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $85.81 | -5,000 | 35.1K | -12% | -$429.1K |
| D | 2023-06-13 | 2023-06-13 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $36.75 | +5,000 | 40.1K | +14% | +$183.8K |
| DM | 2023-06-01 | 2023-06-01 | EW | MUSSALLEM MICHAEL A | Dir | S - Sale+OE | $84.46 | -29.4K | 110.3K | -21% | -$2.48M |
| D | 2023-06-01 | 2023-06-01 | EW | MUSSALLEM MICHAEL A | Dir | M - OptEx | $36.75 | +29.4K | 115.6K | +34% | +$1.08M |
| D | 2023-05-24 | 2023-05-24 | EW | Wood Larry L | Gbl Pres TAVR, Surg | M - OptEx | $45.28 | +6,421 | 220.2K | +3% | +$290.7K |
| D | 2023-05-24 | 2023-05-24 | EW | Wood Larry L | Gbl Pres TAVR, Surg | S - Sale+OE | $84.23 | -6,421 | 213.8K | -3% | -$540.8K |
| 2023-05-17 | 2023-05-17 | EW | Ullem Scott B. | CFO, CVP | G - Gift | $0.00 | -8,496 | 19.2K | -31% | $0 | |
| I | 2023-05-17 | 2023-05-17 | EW | Ullem Scott B. | CFO, CVP | G - Gift | $0.00 | +8,496 | 266.3K | +3% | $0 |
| D | 2023-05-15 | 2023-05-11 | EW | Ullem Scott B. | CFO, CVP | A - Grant | $0.00 | +9,450 | 27.7K | +52% | $0 |
| 2023-05-15 | 2023-05-12 | EW | Sequeira Ramona | Dir | A - Grant | $0.00 | +2,803 | 5,103 | +122% | $0 | |
| D | 2023-05-15 | 2023-05-11 | EW | Chopra Daveen | CVP, TMTT | A - Grant | $0.00 | +6,475 | 25.4K | +34% | $0 |
| 2023-05-15 | 2023-05-12 | EW | Marsh Martha H. | Dir | A - Grant | $0.00 | +2,803 | 31.9K | +10% | $0 | |
| D | 2023-05-15 | 2023-05-11 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | A - Grant | $0.00 | +6,425 | 39.5K | +19% | $0 |
| D | 2023-05-15 | 2023-05-12 | EW | STONE HEISZ LESLIE | Dir | A - Grant | $0.00 | +2,803 | 30.3K | +10% | $0 |
| D | 2023-05-15 | 2023-05-11 | EW | Zovighian Bernard J | Pres | A - Grant | $0.00 | +22.5K | 44.6K | +102% | $0 |
| D | 2023-05-15 | 2023-05-11 | EW | Wood Larry L | Gbl Pres TAVR, Surg | A - Grant | $0.00 | +7,775 | 213.8K | +4% | $0 |
| M | 2023-05-15 | 2023-05-12 | EW | LORANGER STEVEN R | Dir | A - Grant | $0.00 | +3,701 | 56.3K | +7% | $0 |
| 2023-05-15 | 2023-05-12 | EW | VALERIANI NICHOLAS J | Dir | A - Grant | $0.00 | +2,803 | 68.9K | +4% | $0 | |
| D | 2023-05-15 | 2023-05-11 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | A - Grant | $0.00 | +1,800 | 13.0K | +16% | $0 |
| 2023-05-15 | 2023-05-12 | EW | LAVIOLETTE PAUL A | Dir | A - Grant | $0.00 | +2,803 | 7,718 | +57% | $0 | |
| D | 2023-05-15 | 2023-05-11 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | A - Grant | $0.00 | +1,575 | 173.7K | +0.9% | $0 |
| D | 2023-05-15 | 2023-05-11 | EW | Szyman Catherine M. | CVP, Critical Care | A - Grant | $0.00 | +6,525 | 35.1K | +23% | $0 |
| D | 2023-05-15 | 2023-05-12 | EW | MUSSALLEM MICHAEL A | Dir | A - Grant | $0.00 | +4,485 | 86.2K | +5% | $0 |
| M | 2023-05-15 | 2023-05-12 | EW | GALLAHUE KIERAN | Dir | A - Grant | $0.00 | +3,701 | 3,701 | New | $0 |
| D | 2023-05-11 | 2023-05-10 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $36.75 | +2,500 | 35.6K | +8% | +$91.9K |
| D | 2023-05-11 | 2023-05-10 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $89.22 | -2,500 | 33.1K | -7% | -$223.1K |
| DM | 2023-05-11 | 2023-05-10 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $88.54 | -80.7K | 18.3K | -82% | -$7.14M |
| D | 2023-05-11 | 2023-05-10 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $35.20 | +80.7K | 99.0K | +441% | +$2.84M |
| D | 2023-05-11 | 2023-05-10 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | -9,500 | 95.6K | -9% | $0 |
| DI | 2023-05-11 | 2023-05-10 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | +9,500 | 3.62M | +0.3% | $0 |
| DM | 2023-05-11 | 2023-05-10 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | S - Sale+OE | $88.49 | -19.9K | 81.7K | -20% | -$1.76M |
| DM | 2023-05-11 | 2023-05-07+ | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $20.62 | +50.2K | 81.7K | +159% | +$1.03M |
| D | 2023-05-09 | 2023-05-07 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $0.00 | +6,062 | 23.0K | +36% | $0 |
| DM | 2023-05-09 | 2023-05-07+ | EW | Ullem Scott B. | CFO, CVP | F - Tax | $88.74 | -4,678 | 20.0K | -19% | -$415.1K |
| DM | 2023-05-09 | 2023-05-07+ | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | F - Tax | $88.74 | -328 | 172.2K | -0.2% | -$29.1K |
| DM | 2023-05-09 | 2023-05-07+ | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | M - OptEx | $23.38 | +9,995 | 172.4K | +6% | +$233.7K |
| D | 2023-05-09 | 2023-05-09 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | S - Sale+OE | $88.68 | -6,640 | 172.1K | -4% | -$588.8K |
| DM | 2023-05-09 | 2023-05-07+ | EW | Szyman Catherine M. | CVP, Critical Care | F - Tax | $88.74 | -3,530 | 28.5K | -11% | -$313.3K |
| DM | 2023-05-09 | 2023-05-07+ | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $33.14 | +80.3K | 104.1K | +337% | +$2.66M |
| D | 2023-05-09 | 2023-05-09 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $88.94 | -75.6K | 28.5K | -73% | -$6.72M |
| M | 2023-05-09 | 2023-05-07+ | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | F - Tax | $88.74 | -295 | 11.2K | -3% | -$26.2K |
| DM | 2023-05-09 | 2023-05-07+ | EW | Zovighian Bernard J | Pres | F - Tax | $88.74 | -3,756 | 22.0K | -15% | -$333.3K |
| D | 2023-05-09 | 2023-05-07 | EW | Zovighian Bernard J | Pres | M - OptEx | $0.00 | +5,003 | 25.8K | +24% | $0 |
| DM | 2023-05-09 | 2023-05-07+ | EW | Wood Larry L | CVP, Grp Pres TAVR, SSH | F - Tax | $88.74 | -4,055 | 207.8K | -2% | -$359.8K |
| D | 2023-05-09 | 2023-05-07 | EW | Wood Larry L | CVP, Grp Pres TAVR, SSH | M - OptEx | $0.00 | +5,415 | 210.4K | +3% | $0 |
| DM | 2023-05-09 | 2023-05-07+ | EW | Chopra Daveen | CVP, TMTT | F - Tax | $88.74 | -2,789 | 19.9K | -12% | -$247.5K |
| D | 2023-05-09 | 2023-05-07 | EW | Chopra Daveen | CVP, TMTT | M - OptEx | $0.00 | +3,413 | 21.8K | +19% | $0 |
| D | 2023-05-08 | 2023-05-05 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $88.63 | -5,635 | 56.2K | -9% | -$499.4K |
Purchase Sale Sale after option exercise All abbreviations